Ipsen Pharma Sas

France · Reporting entity ID 100000010667

Total reported 2019–2025

$14.6M

#396 of 2,960 reporting companies — 0% of all reported industry payments

$1.42M in general payments across 240 records, plus $13.2M in research funding across 7,172 records.

How it breaks down

General payments $1,422,368

Research funding $13,151,932

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.